Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
42 hedge funds and large institutions have $35.8M invested in Chembio diagnostics, Inc. in 2020 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 10 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 8
50% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 10
8% more capital invested
Capital invested by funds: $33M → $35.8M (+$2.81M)
8% more funds holding
Funds holding: 39 → 42 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
+$2.12M |
| 2 |
FA
Friess Associates
Greenville,
Delaware
|
+$1.04M |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$777K |
| 4 |
RA
Royce & Associates
New York
|
+$744K |
| 5 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$663K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Silvercrest Asset Management
New York
|
-$3.11M |
| 2 |
GS
Gagnon Securities
New York
|
-$1.47M |
| 3 |
GA
Gagnon Advisors
New York
|
-$1.14M |
| 4 |
RC
Roubaix Capital
Denver,
Colorado
|
-$889K |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$780K |
CEMI Hedge Fund Activity: Q1 2020 in Review
42 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q1 2020, worth a combined $35.8M — up 8.5% from $33M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new CEMI positions and 10 closed out — a net gain of 5 holders — while 14 added to existing stakes and 8 trimmed.
The largest buyer was AWM Investment Company, opening a new position worth an estimated $2.12M. The largest seller was Silvercrest Asset Management, exiting entirely with an estimated $3.11M sold.
- 42 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q1 2020, up from 39 in Q4 2019.
- Funds reported $35.8M of Chembio diagnostics, Inc. stock for Q1 2020, up 8.5% quarter-over-quarter.
- 15 funds opened new Chembio diagnostics, Inc. positions in Q1 2020 and 10 closed out, a net change of +5 holders.
- The largest Chembio diagnostics, Inc. buyer in Q1 2020 was AWM Investment Company, an estimated $2.12M added.
- The largest Chembio diagnostics, Inc. seller in Q1 2020 was Silvercrest Asset Management, an estimated $3.11M sold.
Based on aggregated 13F filings for Q1 2020.